MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2174/0115748871288948240325080936

Медицинская библиотека · Reviews on recent clinical trials · 2024

Gender Differences in Patients with Prolactinoma: Single-center Ukrainian Experience.

Voznyak Oleksandr, Zinkevych Iaroslav, Lytvynenko Andrii, Hryniv Nazarii, Ilyuk Roman, Kobyliak Nazarii

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Prolactinomas are the most common type of pituitary gland tumors that secrete overly prolactin. They account for approximately 60% of all hormone-secreting hypophysis tumors.

AIM: This study aims to analyze gender differences in patients with prolactinomas who were operated on transsphenoidal surgery and conduct a single-center retrospective analysis of patient data.

MATERIAL AND

METHODS

This study evaluated the medical records of 109 patients (61 females and 48 males) from 2009 to 2019 at Feofaniya Clinical Hospital of the State Administration of Affairs in Kyiv, Ukraine. The primary criterion for including patients was a Serum Prolactin (PRL) level of over 100 ng/ml and the presence of a pituitary adenoma (PA) as observed on MRI. Additionally, the histological examination needed to confirm the presence of Prolactin-Secreting Pituitary Adenomas (PSPAs) without plurihormonal activity through both microscopy and immunohistochemical (IHC) staining.

RESULTS

Significant differences in preoperative PRL levels were not observed. However, males had significantly larger tumor sizes and prevalence of macroadenomas. In male patients, the preoperative PLR levels showed a weak negative correlation with age (r=-0.304, p < 0.036) and a positive correlation with tumor size (r=0.555, p < 0.001) and cavernous sinus invasion (r=0.339, p < 0.018). In females, preoperative PRL was significantly associated only with tumor size and Knosp grade.

CONCLUSION

Prolactin-Secreting Pituitary Adenomas (PSPAs) are more common in women than men and are characterized by larger and more invasive tumors with high PRL levels at diagnosis. The PRL level and tumor size before surgery can predict early biochemical remission in both males and females with an accuracy of 58.3% and 68.8%, respectively.

Для цитирования: Voznyak Oleksandr, Zinkevych Iaroslav, Lytvynenko Andrii, Hryniv Nazarii, Ilyuk Roman, Kobyliak Nazarii. Gender Differences in Patients with Prolactinoma: Single-center Ukrainian Experience.. Reviews on recent clinical trials. 2024. DOI: 10.2174/0115748871288948240325080936.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.